{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:41:35Z","timestamp":1789472495542,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.euo.2022.09.005","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T09:50:36Z","timestamp":1666345836000},"page":"406-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Magnetic Resonance Imaging\u2013based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification"],"prefix":"10.1016","volume":"6","author":[{"given":"Michael","family":"Baboudjian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Gondran-Tellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alae","family":"Touzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Diamand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Lacetera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Beauval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Roumegu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiseppe","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Benamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Fourcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Fiard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick C.N.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Peltier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Ploussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2022.09.005_b0005","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. ed. 8. Geneva, Switzerland: International Union Against Cancer; 2017. https:\/\/www.uicc.org\/resources\/tnm-classification-malignant-tumours-8th-edition."},{"key":"10.1016\/j.euo.2022.09.005_b0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.09.005_b0015","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00345-019-02762-2","article-title":"Role of MRI in planning radical prostatectomy: what is the added value?","volume":"37","author":"Marenco","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2022.09.005_b0020","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bju.13104","article-title":"Guideline of guidelines: imaging of localized prostate cancer","volume":"116","author":"Wollin","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2022.09.005_b0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS Prostate Imaging-Reporting and Data System: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.09.005_b0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.urology.2014.03.012","article-title":"The impact of multiparametric pelvic magnetic resonance imaging on risk stratification in patients with localized prostate cancer","volume":"84","author":"Marcus","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.euo.2022.09.005_b0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2019.04.023","article-title":"Impact of magnetic resonance imaging on prostate cancer staging and European Association of Urology risk classification","volume":"130","author":"Draulans","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.euo.2022.09.005_b0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.urology.2020.08.089","article-title":"Multiparametric magnetic resonance imaging should be preferred over digital rectal examination for prostate cancer local staging and disease risk classification","volume":"147","author":"Soeterik","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.euo.2022.09.005_b0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.eururo.2021.07.027","article-title":"Risk stratification of patients candidate to radical prostatectomy based on clinical and multiparametric magnetic resonance imaging parameters: development and external validation of novel risk groups","volume":"81","author":"Mazzone","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.09.005_b0050","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2022.09.005_b0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(21)02437-5","article-title":"Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol","volume":"399","author":"Attard","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2022.09.005_b0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2022.09.005_b0065","doi-asserted-by":"crossref","first-page":"djw039","DOI":"10.1093\/jnci\/djw039","article-title":"Efficiency of prostate cancer diagnosis by MR\/ultrasound fusion-guided biopsy vs standard extended-sextant biopsy for MR-visible lesions","volume":"108","author":"Siddiqui","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euo.2022.09.005_b0070","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2022.09.005_b0075","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2022.09.005_b0080","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00345-019-02634-9","article-title":"A multicentric study on accurate grading of prostate cancer with systematic and MRI\/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy","volume":"37","author":"Diamand","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2022.09.005_b0085","first-page":"CD012663","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","volume":"2019","author":"Drost","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euo.2022.09.005_b0090","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/JU.0000000000000418","article-title":"Added value of concomitant systematic and fusion targeted biopsies for grade group prediction based on radical prostatectomy final pathology on positive magnetic resonance imaging","volume":"202","author":"Ploussard","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2022.09.005_b0095","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3390\/jcm9123841","article-title":"MRI characteristics accurately predict biochemical recurrence after radical prostatectomy","volume":"9","author":"Manceau","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.euo.2022.09.005_b0100","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF01613004","article-title":"Prognostic grouping: the next step in tumor classification","volume":"116","author":"Hermanek","year":"1990","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.euo.2022.09.005_b0105","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.euo.2019.06.001","article-title":"Imaging and T category for prostate cancer in the 8th edition of the Union for International Cancer Control TNM classification","volume":"3","author":"van der Poel","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2022.09.005_b0110","doi-asserted-by":"crossref","first-page":"e051274","DOI":"10.1136\/bmjopen-2021-051274","article-title":"Detection of ISUP \u22652 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS vol 2.1 score (CHANGE study)","volume":"12","author":"Rouvi\u00e8re","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.euo.2022.09.005_b0115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1148\/radiol.2019190938","article-title":"Classification of cancer at prostate MRI: deep learning versus clinical PI-RADS assessment","volume":"293","author":"Schelb","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2022.09.005_b0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41585-019-0193-3","article-title":"A new era: artificial intelligence and machine learning in prostate cancer","volume":"16","author":"Goldenberg","year":"2019","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2022.09.005_b0125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.euo.2018.12.002","article-title":"Defining the most informative intermediate clinical endpoints for predicting overall survival in patients treated with radical prostatectomy for high-risk prostate cancer","volume":"2","author":"Martini","year":"2019","journal-title":"Eur Urol Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931122001699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931122001699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:49:19Z","timestamp":1762876159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931122001699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2588931122001699"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2022.09.005","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnetic Resonance Imaging\u2013based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2022.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}